Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Progressive MS Alliance Industry Forum: Maximizing Collective Impact To Enable Drug Development.
Addressing Concerns Regarding the Use of Gadolinium in a Standardized MRI Protocol for the Diagnosis and Follow-Up of Multiple Sclerosis.
Quantifying the relationship between increased disability and health care resource utilization, quality of life, work productivity, health care costs in patients with multiple sclerosis in the US.
Risk Factors, Epidemiology and Treatment Strategies for Metabolic Bone Disease in Patients with Neurological Disease.
The devil is in the detail: Acute Guillain-Barré syndrome camouflaged as neurosarcoidosis in a critically ill patient admitted to an Intensive Care Unit.
Assessment of IL-17A, IL-10 and TGF-beta1 serum titers in RRMS patients treated with Avonex, possible biomarkers for treatment response.
Chemical proteomic map of dimethyl fumarate-sensitive cysteines in primary human T cells.
Risk of Multiple Sclerosis in Patients with Psoriasis: A Danish Nationwide Cohort Study.
Study Confirms Natalizumab Efficacy, Safety in Treating RRMS
Demyelination causes synaptic alterations in hippocampi from multiple sclerosis patients.
Methods for assessing the regenerative responses of neural tissue.
Mixed emotions: the contribution of alexithymia to the emotional symptoms of autism.
A clinical update on the significance of the gut microbiota in systemic autoimmunity.
Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression.
MicroRNA regulate immune pathways in T-cells in multiple sclerosis (MS).
Statins: a revised appraisal for potential additional future treatment indications.
An anticomplement agent that homes to the damaged brain and promotes recovery after traumatic brain injury in mice.
Calcium CaV1 Channel Subtype mRNA Expression in Parkinson's Disease Examined by In Situ Hybridization.
Histopathological effects of intramuscular metamizole sodium on rat sciatic nerve.
Modulation of the immune system by UV radiation: more than just the effects of vitamin D?
Shift work at young age is associated with increased risk of multiple sclerosis in a Danish population.
Neuroprotective Effect of Genistein In Peripheral Nerve Injury.
Immune recognition of citrullinated epitopes.
Long Term Clinical Prognostic Factors in Relapsing-Remitting Multiple Sclerosis: Insights from a 10-Year Observational Study.
Hyperphosphorylation and aggregation of tau in experimental autoimmune encephalomyelitis.
Pages
« first
‹ previous
…
694
695
696
697
698
699
700
701
702
…
next ›
last »